Susquehanna International Group
OMIC

Susquehanna International Group’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Susquehanna International Group’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,704
Closed -$26.3K – 13505
2024
Q1 		$26.3K Buy
+1,704
New +$26K ﹤0.01% 11756
2023
Q3 		– Sell
-3,601
Closed -$89.7K – 13251
2023
Q2 		$89.7K Buy
3,601
+850
+31% +$24.9K ﹤0.01% 11029
2023
Q1 		$99.9K Buy
2,751
+2,048
+291% +$125K ﹤0.01% 11300
2022
Q4 		$42.4K Sell
703
-38
-5% -$2.55K ﹤0.01% 11477
2022
Q3 		$56K Buy
741
+236
+47% +$24.7K ﹤0.01% 12126
2022
Q2 		$58K Sell
505
-64
-11% -$7.51K ﹤0.01% 11890
2022
Q1 		$108K Buy
+569
New +$132K ﹤0.01% 11853

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Susquehanna International Group's OMIC Position: Q2 2024 in Review

Susquehanna International Group sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 1,704 shares — an estimated $26.3K sold.

Susquehanna International Group first reported a position in OMIC in Q1 2022 and held it in 7 quarters. The position peaked at $108K in Q1 2022. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Susquehanna International Group reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 1,704 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $26.3K.
  • Susquehanna International Group first reported a position in Singular Genomics Systems, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Susquehanna International Group's Singular Genomics Systems, Inc. Common Stock position peaked at $108K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.